218 related articles for article (PubMed ID: 26885339)
1. A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
Kashipazha D; Mohammadianinejad SE; Majdinasab N; Azizi M; Jafari M
Iran J Neurol; 2015 Oct; 14(4):204-10. PubMed ID: 26885339
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
[TBL] [Abstract][Full Text] [Related]
3. Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder.
Eskandarieh S; Moghadasi AN; Sahraiain MA; Azimi AR; Molazadeh N
Iran J Neurol; 2019 Jul; 18(3):93-98. PubMed ID: 31749929
[No Abstract] [Full Text] [Related]
4. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Papais-Alvarenga RM; Vasconcelos CC; Carra A; de Castillo IS; Florentin S; Diaz de Bedoya FH; Mandler R; de Siervi LC; Pimentel ML; Alvarenga MP; Alvarenga MP; Grzesiuk AK; Gama Pereira AB; Gomes Neto AP; Velasquez C; Soublette C; Fleitas CV; Diniz DS; Armas E; Batista E; Hernandez F; Pereira FF; Siqueira HH; Cabeça H; Sanchez J; Brooks JB; Gonçalves MV; Barroso MC; Ravelo ME; Castillo MC; Ferreira ML; Rocha MS; Parolin MK; Molina O; Marinho PB; Christo PP; Brant de Souza R; Pessanha Neto S; Camargo SM; Machado SC; Neri VC; Fragoso YD; Alvarenga H; Thuler LC
PLoS One; 2015; 10(7):e0127757. PubMed ID: 26222205
[TBL] [Abstract][Full Text] [Related]
5. Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients.
Sahraian MA; Moinfar Z; Khorramnia S; Ebrahim MM
Eur J Neurol; 2010 Jun; 17(6):794-9. PubMed ID: 20100229
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience.
Jagtap SA; Mandliya A; Sarada C; Nair MD
J Neurosci Rural Pract; 2015; 6(3):331-5. PubMed ID: 26167014
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
[TBL] [Abstract][Full Text] [Related]
10. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
11. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of neuromyelitis optica.
Wingerchuk DM
Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Jacob A; Panicker J; Lythgoe D; Elsone L; Mutch K; Wilson M; Das K; Boggild M
J Neurol; 2013 Aug; 260(8):2134-7. PubMed ID: 23689970
[TBL] [Abstract][Full Text] [Related]
15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
16. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica].
Liu WD; Yu MY; Jiang LB
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):228-233. PubMed ID: 30841690
[TBL] [Abstract][Full Text] [Related]
17. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study.
Ashtari F; Safaei A; Shaygannejad V; Najafi MA; Vesal S
J Res Med Sci; 2017; 22():41. PubMed ID: 28465700
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
Weinshenker BG; Wingerchuk DM
Curr Top Microbiol Immunol; 2008; 318():343-56. PubMed ID: 18219825
[TBL] [Abstract][Full Text] [Related]
20. Specificity of Lower Urinary Tract Symptoms in Neuromyelitis Optica in Comparison With Multiple Sclerosis Patients.
Declemy A; Chesnel C; Charlanes A; Le Breton F; Ismael SS; Amarenco G
Int Neurourol J; 2018 Sep; 22(3):185-191. PubMed ID: 30286581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
